Cargando…
Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey
BACKGROUND: Pseudomonas aeruginosa is the third most common pathogen responsible for nosocomial infections and the prevalence of multiple resistant isolates has been increasing. Ninety-nine clinical isolates were studied in order to assess the current levels of susceptibility and cross-resistances o...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149377/ https://www.ncbi.nlm.nih.gov/pubmed/12437779 http://dx.doi.org/10.1186/1476-0711-1-2 |
_version_ | 1782120623922741248 |
---|---|
author | Gençer, Serap Ak, Öznur Benzonana, Nur Batırel, Ayşe Özer, Serdar |
author_facet | Gençer, Serap Ak, Öznur Benzonana, Nur Batırel, Ayşe Özer, Serdar |
author_sort | Gençer, Serap |
collection | PubMed |
description | BACKGROUND: Pseudomonas aeruginosa is the third most common pathogen responsible for nosocomial infections and the prevalence of multiple resistant isolates has been increasing. Ninety-nine clinical isolates were studied in order to assess the current levels of susceptibility and cross-resistances of widely used antipseudomonal antibiotics against P. aeruginosa and to determine some resistance mechanisms by phenotypic methods. METHODS: MICs of isolates for nine antipseudomonal antibiotics were determined by the E test method. RESULTS: Thirty-six percent of isolates were resistant to more than one group of antibiotics. The rates of susceptible isolates were ciprofloxacin 75%, amikacin 73%, ceftazidime 65%, meropenem 63%, imipenem 63%, piperacillin/tazobactam 60%, cefoperazone/sulbactam 59%, cefepime 54% and tobramycin 44%. The majority of carbapenem resistant isolates were susceptible to ciprofloxacin and amikacin. CONCLUSION: Ciprofloxacin seems to be the most active agent against P. aeruginosa followed by amikacin in our unit. The usefulness of combinations of these antibiotics and β-lactams should be tested in treating multi-drug resistant P. aeruginosa. |
format | Text |
id | pubmed-149377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1493772003-02-25 Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey Gençer, Serap Ak, Öznur Benzonana, Nur Batırel, Ayşe Özer, Serdar Ann Clin Microbiol Antimicrob Research BACKGROUND: Pseudomonas aeruginosa is the third most common pathogen responsible for nosocomial infections and the prevalence of multiple resistant isolates has been increasing. Ninety-nine clinical isolates were studied in order to assess the current levels of susceptibility and cross-resistances of widely used antipseudomonal antibiotics against P. aeruginosa and to determine some resistance mechanisms by phenotypic methods. METHODS: MICs of isolates for nine antipseudomonal antibiotics were determined by the E test method. RESULTS: Thirty-six percent of isolates were resistant to more than one group of antibiotics. The rates of susceptible isolates were ciprofloxacin 75%, amikacin 73%, ceftazidime 65%, meropenem 63%, imipenem 63%, piperacillin/tazobactam 60%, cefoperazone/sulbactam 59%, cefepime 54% and tobramycin 44%. The majority of carbapenem resistant isolates were susceptible to ciprofloxacin and amikacin. CONCLUSION: Ciprofloxacin seems to be the most active agent against P. aeruginosa followed by amikacin in our unit. The usefulness of combinations of these antibiotics and β-lactams should be tested in treating multi-drug resistant P. aeruginosa. BioMed Central 2002-10-09 /pmc/articles/PMC149377/ /pubmed/12437779 http://dx.doi.org/10.1186/1476-0711-1-2 Text en Copyright © 2002 Gençer et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Research Gençer, Serap Ak, Öznur Benzonana, Nur Batırel, Ayşe Özer, Serdar Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey |
title | Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey |
title_full | Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey |
title_fullStr | Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey |
title_full_unstemmed | Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey |
title_short | Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey |
title_sort | susceptibility patterns and cross resistances of antibiotics against pseudomonas aeruginosa in a teaching hospital of turkey |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149377/ https://www.ncbi.nlm.nih.gov/pubmed/12437779 http://dx.doi.org/10.1186/1476-0711-1-2 |
work_keys_str_mv | AT gencerserap susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey AT akoznur susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey AT benzonananur susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey AT batırelayse susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey AT ozerserdar susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey |